Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

CEO

Dr. Arron Tolley

Market Cap

28.03 Million GBp

Sector

Healthcare

Website

https://aptamergroup.com

Description

Aptamer Group plc provides binders for research, diagnostics, and therapeutics in the United Kingdom and internationally.

Read More

Overview

Value

2

Growth

45

Health

47

Management

24

Analyst Opinion

0

Total

30

All Scores Out Of 100

Best Features

  • Earnings growth has improved recently
  • Has a low level of debt
  • Low preportion of income is paid as dividend
  • 0

Risk Factors

  • Overvalued on cashflow basis
  • Earnings are negative
  • No margin of safety at their current market price

Market Peers

APTA.L

Key Figures

PE Ratio (TTM)

N/A

Margin Of Safety (DCF)

-101.15%

Revenue Growth (5 Year Average)

25.73%

Ratings Consensus

N/A

Share Buybacks

N/A

Dividend Yeild (TTM)

N/A

Valuation

Value Score

2

  • Estimated intrinsic-value of NaN undefined GBp is lower than current price ( 40.60 GBp)
  • Free-cashflow-yeild of N/A is worse than the market average (4.7%)
  • Margin-of-safety of -101.15% is worse than the market average (17.95%)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: N/A

Current Price: 39 GBp

Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

N/Ax

Free Cashflow Yeild

N/A

PE/Earnings Growth

N/A

Price/Book

33447.48x

Growth

Growth Score

45

  • 5 Year Average Revenue growth of 25.73% is higher than the market average (10.97%)
  • Earnings growth has improved this year
  • 5 Year Average Cashflow growth of 24.53% is higher than the market average (12.35%)
  • Revenue growth has slowed this year
  • 5 Year Average Earnings growth of -21.67% is lower than the market average (14.48%)
  • Free Cashflow growth has slowed this year

Revenue Growth

25.73%

Earnings Growth

-21.67%

Cashflow Growth

24.53%

Health

Health Score

47

  • Has a low level of debt
  • Assets cover liabilities
  • Low financial Leverage
  • Normal operation does not require debt to be sustainable
  • Debt repayments significantly impact cashflow

Altman Z Score

N/A

Piostroski Score

N/A

Debt/Equity

0.16x

Current Assets/Liabilities

10.35x

Free Cashflow/Total Debt

N/Ax

Debt/Capital

0.15x

Management

Management Score

24

  • Has not bought shares or issued new shares in the last 5 years
  • Return-on-capital-employed of -14.62% is lower than the market average (10%)
  • Return-on-equity of -2603.67% is lower than the market average (15%)

Average Buybacks/Dilution

N/A

Recent Buybacks/Dilution

N/A

5 Year Price Volitility

23.28%

Return On Assets

-1819.63%

Return On Capital Employed

-14.62%

Return On Equity

-2603.67%

Return On Free Cashflow

86072.73%

Return On Investments

N/A

Analysts

Analyst Opinion

0

    SEC Filings

    Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

    Other Information

    Company Name

    Aptamer Group plc

    Currency

    GBp

    Beta

    0

    Vol Avg

    11713

    Ceo

    Dr. Arron Tolley

    Cik

    Cusip

    Exchange

    London Stock Exchange

    Full Time Employees

    Industry

    Biotechnology

    Sector

    Healthcare

    Ipo Date

    2021-12-22

    Address

    Bio Centre

    City

    York

    State

    Country

    GB

    Zip

    YO10 5NY

    Phone

    44 1904 567 790

    All financial data provided by FMP

    Noticed an error with something on our site?

    We Use Cookies